PDUFA Dates: January 2026
2 FDA target action dates in January 2026. Each PDUFA date is the FDA's deadline to complete review of a drug application.
Mix: 1 NDA, 1 unspecified.
Aquestive Therapeutics, Inc. AQST
Anaphylm (dibutepinephrine sublingual film) Type I allergic reactions (anaphylaxis)
NDA
Jan 31, 2026
168 days ago
Pharming Group N.V. PHAR
0 Jan 31, 2026
168 days ago